Upon activation, C3 is cleaved and deposited on pathogenic cells (27), which means that an active infection or pathogenic condition is expected to reduce C3 levels in the blood as shown for bladder cancer patients (28). The gene discussed is C3; the disease is urinary bladder carcinoma.